About this trial
This randomized clinical trial evaluates the efficacy of sodium hypochlorite (NaOCl), chlorhexidine (CHX), and cold saline as hemostatic agents in partial pulpotomy. The study compares postoperative pain (via VAS scores) and pulp survival (via clinical/radiographic evaluation) at 1, 3, 7 days, 6 months, and 12 months
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Permanent teeth with carious pulp exposure (no spontaneous pain).
Positive vitality test (Endo-Ice).
No periapical radiolucency.
Disqualifiers
Systemic diseases affecting healing.
Pregnancy.
Non-vital pulp/necrosis
Trial design
Parallel
Treatments tested in this trial
Sodium Hypochlorite 2,5%
Drug2.5% NaOCl applied for 1 min to exposed pulp for hemostasis, followed by standard pulp capping
Chlorhexidine
Drug2% CHX applied for 1 min to achieve hemostasis, with identical subsequent steps to NaOCl group
Cold Saline
DrugHemostasis via 4°C saline (1 Min), then standardized pulp capping
Treatment groups
Trial outcomes
Primary outcomes
Postoperative Pain
The patient will be asked to rate the pain on the 1st, 3rd and 7th day according to VAS. (The patient is asked to score their pain in this range, with 0 being the lowest and 10 being the highest.)
Pulp Survival Rate
The pulp is expected to be vital, without percussion tenderness and without spontaneous pain
Secondary outcomes
Clinical Success
Maintaining the integrity of the restoration No need for endodontics treatments
Sponsors and contacts
Click on the lead sponsor to view all of their trials.